In addition to the note, the Company has agreed to issue 200,000 shares of its common stock to Labrys as commitment shares, further enhancing the financing arrangement. The proceeds from the SPA will be allocated as follows: $114,000 will be wired directly to the Company, $7,500 will be paid to Enclave Capital LLC as placement agent compensation, $25,000 will be used to repay a portion of a prior promissory note, and $3,500 will cover Labrys' legal fees. Furthermore, the Company has authorized its transfer agent to reserve an initial 12,000,000 shares of common stock for potential issuance upon conversion of the note, which may be adjusted over time according to the note's terms.
This financing arrangement is expected to provide the Company with necessary liquidity to support its operational needs and strategic initiatives. However, the issuance of additional shares may lead to dilution for existing shareholders, which is a factor to consider moving forward. Overall, this development is viewed positively as it strengthens the Company's financial position, although the potential dilution could temper the immediate positive impact on stock price.